Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Treg Cells Chronic Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (60)
Bortezomib Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P3	B (59)
Monomethyl Fumarate Leukemia, Myeloid	Masonic Cancer Center, University of Minnesota	P3	B (59)
Evomela Minimal Residual Disease	Masonic Cancer Center, University of Minnesota	P2	B (59)
Rapamycin Myelofibrosis	Masonic Cancer Center, University of Minnesota	P2	B (59)
Allopurinol Myelodysplastic Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (58)
Cyclophosphamide Hemoglobinopathy	Masonic Cancer Center, University of Minnesota	P2	B (58)
Inno-206 TP53	Masonic Cancer Center, University of Minnesota	P2	B (58)
PREDNISONE TABLETS TP53	Masonic Cancer Center, University of Minnesota	P2	B (58)
TACROLIMUS Hemoglobinopathy	Masonic Cancer Center, University of Minnesota	P2	B (58)
Allopurinol Burkitt Lymphoma	Masonic Cancer Center, University of Minnesota	P2	B (57)
Allopurinol Chronic Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (57)
Allopurinol Prolymphocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (57)
Busulphan Aspartylglucosaminuria	Masonic Cancer Center, University of Minnesota	P2	B (57)
Busulphan Mucopolysaccharidosis Type 2	Masonic Cancer Center, University of Minnesota	P2	B (57)
Busulphan Hurler Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Busulphan Lymphoplasmacytic Lymphoma	Masonic Cancer Center, University of Minnesota	P2	B (57)
Busulphan Mucopolysaccharidosis	Masonic Cancer Center, University of Minnesota	P2	B (57)
Busulphan Peroxisomal Disease	Masonic Cancer Center, University of Minnesota	P2	B (57)
Busulphan Mucopolysaccharidosis Type 7	Masonic Cancer Center, University of Minnesota	P2	B (57)
Busulphan Sphingolipidosis	Masonic Cancer Center, University of Minnesota	P2	B (57)
Cyclophosphamide Hemophagocytic Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Cyclophosphamide X-Linked Lymphoproliferative Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
FILGRASTIM Wiskott-Aldrich Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Fludarabine Alpha Mannosidosis	Masonic Cancer Center, University of Minnesota	P2	B (57)

Showing 101 to 125 of 705 assets

PreviousPage 5 of 29Next